BioRender 图标

Endothelial cell 1 (dying 2)

Endothelial cell 1 (dying 2) - Editable icon of a dying flat, rectangular endothelial cell with a domed nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/636524346b73320021b58769/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524346b73320021b58769/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524346b73320021b58768/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524346b73320021b58768/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5879b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5879b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5879a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5879a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58799/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58799/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58798/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58798/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58797/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58797/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58796/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58796/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58795/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58795/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58794/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58794/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58793/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58793/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58792/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58792/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58791/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58791/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58790/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58790/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5878a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5878a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58789/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58789/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58788/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58788/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58787/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58787/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58786/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58786/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58785/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58785/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58784/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58784/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58783/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58783/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58782/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58782/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58781/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58781/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58780/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58780/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5877a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5877a/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58779/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58779/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58778/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58778/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58777/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58777/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58776/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58776/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58775/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58775/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58774/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58774/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58773/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58773/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58772/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58772/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58771/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58771/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b58770/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b58770/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876f/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876f/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876e/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876e/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876d/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876d/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876c/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876c/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876b/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876b/63628e6f99665a0021bbba2b.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636524536b73320021b5876a/63628e6f99665a0021bbba2b.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636524536b73320021b5876a/63628e6f99665a0021bbba2b.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
endothelial,endothelium,endothelia,blood vessel,vessel,capillary,alveolar,BBB,leaky BBB,blood,lymphatic,lymphatic vessel,circulatory,cardiovascular,circulatory system,cardiovascular system,blood brain barrier,dying,dead,degrade,degradation,die,compromised,necrosis,necrotic,cell death,damaged,disintegrate,disintegration
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Endothelial cell 1 (dying 2) icon JPEG

Endothelial cell 1 (dying 2) icon PNG

Endothelial cell 1 (dying 2) icon SVG

Endothelial cell 1 (dying 2) icon GIF

BioRender 图标常见问题解答

How are scientists using the Endothelial cell 1 (dying 2) icon in their work?

BioRender users often use the Endothelial cell 1 (dying 2) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Endothelial cell 1 (dying 2) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Endothelial cell 1 (dying 2) icon customizable in BioRender?

Most icons in BioRender, including the Endothelial cell 1 (dying 2) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Endothelial cell 1 (dying 2) icon for publication or presentations?

Yes, figures containing the Endothelial cell 1 (dying 2) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Endothelial cell 1 (dying 2) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Endothelial cell 1 (dying 2) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Endothelial cell 1 (dying 2) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon